Keywords: Myocardium, Cardiomyopathy
Motivation: Improve assessment of early-stage hypertrophic cardiomyopathy (HCM) by MRI.
Goal(s): That DT-CMR can identify cardiac microstructural abnormalities in young variant carriers before the onset of symptoms or hypertrophy in HCM, and that these changes may not occur in their genetically unaffected siblings.
Approach: Early stage sarcomere gene variant carriers were recruited; 30 SARC+ and 30 SARC- controls. Cardiac diffusion tensor imaging was performed to assess sensitivity of diffusion to early-stage HCM.
Results: Among the DT-CMR parameters in SARC+ and SARC-control subjects, the diastolic E2A mean over the SA slice was significantly higher in the SARC+ cohort compared to the SARC- group.
Impact: HCM is linked to the risk of sudden cardiac death and heart failure. There are now novel treatments that may cure HCM. Our study highlights the role of DT-CMR in identifying individuals who may benefit from these treatments.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords